Protein Complex and Protein protein Interaction
Protein Complex and
Protein Complex and
Protein-protein Interaction
Protein-protein Interaction
彭彭彭 国家人类基因组北方研究中心 Email: pengkp@yahoo.com.cn
Protein is the final player in cell life
Protein is the final player in cell life
Central dogma: Central dogma: the story of life the story of life DNA RNA Protein
Proteins function in association with
Proteins function in association with
other proteins or biomolecules, but
other proteins or biomolecules, but
not in isolation
not in isolationIntroduction to Proteomics Introduction to Proteomics
the analysis of genomic complements of proteins
dynamic
systematic
discovery-driven
Goals of Proteomics
Goals of Proteomics
to discover protein function to understand cellular processes to understand disease states to discover drug target to identify biomarker
Types of Proteomics
Types of Proteomics
Expression Proteomics
- – their changes between samples that differs by some variable
Quantitative study of protein expression and
Functional Proteomics
- – structures, cellular localization and PTMs in order to understand the physiological function of the whole set of proteome.
To study protein-protein interaction , 3-D
Approaches
ApproachesGenetic: Biophysical: yeast two-hybrid Mass Spectrometry phage display SPR
FRET Biochemical: Blue native PAGE Far Western
Bioinformatic:
Pull-down Co-occurrence Coimmunoprecipitation Neighborhood TAP Surface patch Crosslinking
Blue Native PAGE Blue Native PAGE
separation of native proteins in complex.
Coomassie Blue G: stable and negatively charge multiprotein complex.
6-aminocaproic acid: solubilize membrane protein complex instead of salts.
the resolution is not so high that the prepurification is needed.
Blue Native PAGE
Blue Native PAGE
_
detergent CBB 6-ACA
Blue Native PAGE
Solubilization with nonionic detergent (laurylmaltoside, TX-100, Sample Preparation CHAPS, Mega 9, octylglucoside,
Brij 35, etc), supplemented with 6-aminocaproic acid Blue Native PAGE Separation gel: 6-13% gradient
Cathode buffer contains 0.02% Coomassie blue G250 SDS-PAGE Separation of members of multiprotein complex Blue Native PAGE of chloroplast Blue Native PAGE of chloroplast thylakoid membranes thylakoid membranes
BN-PAGE of solubilized chloroplast thylakoid membranes (a) followed by SDS–PAGE in the second dimension (b). CF F ATP synthase was 1 indicated. Blue Native PAGE of chloroplast Blue Native PAGE of chloroplast thylakoid membranes thylakoid membranes
lane 1: LMW marker lane 2: CF F ATP synthase, 1 purified by density gradient centrifugation lane 3: electroeluted protein from the intense band (Rf= 0.38) in BN-PAGE (a). Blue Native PAGE of multiprotein Blue Native PAGE of multiprotein complex from whole cellular lysate complex from whole cellular lysate
Dialysis permits the analysis of multiprotein complexes of whole cellular lysates by BN- PAGE. Blue Native PAGE Blue Native PAGE
Identification and analysis of distinct proteasomes by WCL 2D BN/SDS-PAGE
by 2D BN/SDS-PAGE (5.5–14 and 10%, respectively), and immunoblotting was performed with specific antibodies recognizing either subunits of the 20S core complex (Mcp21 and 2), or a subunit of the 19S cap of the 26S proteasome (S4 ATPase), or a subunit of the PA28 regulatory subunit (PA28).
B , An identical sample was
boiled in 1% SDS, resolved by
2D BN/SDS-PAGE, and immunoblotted as described in
A. Blue Native PAGE Blue Native PAGE
Visualization of MPCs on a 2D WCL BN/ SDS gel
A, WCL of HEK293 cells was prepared
B, WCL of HEK293 cells was using Triton X-100 and separated by boiled with 1% SDS before
2D BN/SDS-PAGE (5.5–17 and 10%, separation and staining. respectively).
Far Western
Far Western Far Western Far Western
Max: functional cloning of a Myc-binding protein Max: functional cloning of a Myc-binding protein A. MycC9 CKII, casein kinase II phosphorylation 2 site; BR, basic region; HLH, helix-loop- helix; LZ, leucine zipper.
B. Plaques that express beta-galactosidase fusion prteins were screened for their ability 125 to react with I-labeld GST-MycC92. Top left, secondary plating of five putative positive demonstrates the reactivity of two of the primary plaques, Max11 and Max14.
Top right, as a negative control, GST was labeled to a similar specific activity and compared with GST-MycC92 for bidning to Max14 plaques. Bottom, binding of GST- MycC92 to Mzx14 plaques was assayed with or without affinity purified carboxyl terminal-specific anti-Myc (Ab) or peptide immunogen (peptide). Far Western Far Western
Association of Rb with HIP1
Association of Rb with HIP1
HeLa nulear extract (~100 ug) (lane 1, 2) and HIP1 (~200 ng) purified from HeLa (lane 3, 4) were electrophoresed, blotted, and renatured in situ. Adjacent strips were cut from the filters and probed 32 with P-GST-RB(379-928) (lane 1, 32
3) or P-GST-RB(379-928;706F) (lane 2, 4)
GST Pulldown
GST Pulldown GST Pulldown GST Pulldown
Interactions of Cellular Polypeptides with the Cytoplasmic Domain of the Mouse Fas Antigen
Fas: 45-kilodalton transmembrane receptor that initiates apoptosis; The biochemical mechanisms responsible for Fas action are incompletely understood; the cytoplasmic domain is clearly necessary for Fas to function as a receptor; The cytoplasmic domain does not display any known enzymatic activities but is capable of interacting with a number of proteins. GST Pulldown GST Pulldown 1 149 166 204 293 306 GST-mFas fusion proteins 194 292 194 306 194 194 283 276 194 221
194 268
221 306 194 306GST Pulldown GST Pulldown
32 GST-mFas-associated polypeptides from S- labeled HeLa, L929, and Jurkat cell lysates
Preclearation : 25 ug GST/50 ul GSH-Seph.
Incubation : 10 ug GST/GST-
mFas-(194-306)
Wash : 0.5% NP-40, 20 mM
Tris, pH 8.0, 200 mM NaCl
Elution : 50 ul 20 mM GSH in 50
mM Tris GST Pulldown GST Pulldown
GST-mFas-associated polypeptides GST-mFas-associated polypeptides are stable to high salt concentrations are stable to high salt concentrations
HeLa cell lysates were screened with either GST or GST-mFas- (194–306) as described above except that the Sepharose- protein complexes were washed with Lysis Buffer containing different salt concentrations (as indicated). The eluted material was subjected to 12% SDS- PAGE and fluorography. GST Pulldown GST Pulldown
Association is blocked by preincubation with a polyclonal antibody against GST-mFas
A. the antibody recognized the Fas intracellular domain;
B. association of proteins from HeLa lysate with GST-mFas was blocked by anti-GST- mFas IgG;
C. anti-GST antibody had no effect up to 100 ug of IgG.
GST Pulldown
Differential association with mutant forms of GST-mFas GST Pulldown
HeLa L929 292 283 276 268 221
Schematic representation of the mouse Fas antigen and its binding proteins GST Pulldown
GST Pulldown
GST Pulldown GST Pulldown
Epitope tagging Epitope tagging 1
2
3 6-9
4 5 Co-Immunoprecipitation
Co-Immunoprecipitation
In the intact cell, protein X is present in a complex with protein Y. This complex is preserved after cell lysis and allows protein Y to be coimmunoprecipitated with protein X (complex 1). However, the disruption of subcellular compartmentalization could allow artifactual interactions to occur between some proteins, for example, protein X and protein B (complex 2). Furthermore, the antibody that is used for the immunoprecipitation may cross-react nonspecifically with other proteins, for example, protein A (complex 3). The key to identification of protein:protein interactions by coimmunoprecipitation is to perform the proper controls so as to identify protein Y but not protein A and B. Co-Immunoprecipitation Co-Immunoprecipitation
Antibody Identification The protein against which the antibody was raised should be precipitated from cell lysate. (1) Independent antibodies raised against the same protein recognize the same polypeptide; (2) Target protein should not be identified with antibodies from cell lines without target protein; Co-Immunoprecipitation Co-Immunoprecipitation
False positive and control
False positive and control
1. Antibody control Monoclonal Ab: another MoAb against similar protein Antiserum: serum before immunization from the same animal Polyclonal Ab: purified PoAb against another protein
2. Multiple antibodies different Abs against different epitopes; the epitope may be the site for association with other proteins;
3. Cell lines depleted of target protein Control experiment should be practised in depleted cell lines
4. Inactive biological mutant
5. Interaction verification before and after cell lysis unphysiological interaction Co-Immunoprecipitation Co-Immunoprecipitation
Reduction of nonspecific protein Reduction of nonspecific protein background background
1. to increase ionic strength in wash buffer; 2. to reduce the amount of primary Ab; 3. to preclear cell lysate with control Ab. Binding of pVHL to Elongin B and C Binding of pVHL to Elongin B and C
Co-Immunoprecipitation Co-Immunoprecipitation
1. von Hippel-Lindau disease is a hereditary cancer
1. von Hippel-Lindau disease is a hereditary cancer
syndrome characterized by the development of multiple
syndrome characterized by the development of multiple
tumors;
tumors;
2. VHL susceptibility gene, mutated in the majority of
VHL kindreds, is a tumor suppressor;
VHL kindreds, is a tumor suppressor;
3. to elucidate the biochemical mechanisms underlying
3. to elucidate the biochemical mechanisms underlying
tumor suppression by pVHL, search for cellular proteins
tumor suppression by pVHL, search for cellular proteins
that bound to wt pVHL, but not to tumor-derived pVHL
that bound to wt pVHL, but not to tumor-derived pVHL mutants. mutants. Co-Immunoprecipitation Co-Immunoprecipitation
Identification of VHL-associated proteins
Identification of VHL-associated proteins
Lysates from 786-O renal carcinoma cells, transfected with the indicated pVHL constructs, were immunoprecipitated with anti-HA (A and B) or with anti- VHL (C).
Detection by autoradiography (A, C) or by immunoblotting (B). anti-VHL open arrows: exo pVHL closed arrows: VHL-AP
pVHL(1-115): without residues frequently altered by naturally occurring VHL mutations and, unlike pVHL(wt), does not suppress tumor formation in vivo. pVHL(167W): the predicted product of a mutant VHL allele that is common in VHL families. Co-Immunoprecipitation Co-Immunoprecipitation
Mapping the p14 and p18 binding
Mapping the p14 and p18 binding
site on pVHL
site on pVHL
A. 786-O cells producing HA-VHL(wt) or HA- 35 VHL(1-115) were labeled with S-methione, lysed, and immunoprecipitated with anti-HA.
Parental 786-O cells were similarly labeled, lysed, and incubated with GSH Sepharose preloaded with GST-VHL(117-213) or GST alone. B and C. 786-O cells were labeled, lysed, and incubated with GSH Sephorase preloaded with the indicated GST-VHL fusion protein. In (C), the indicated peptides (final conc. ~0.1, 1, or 10 uM) a-HA were added to the GST-VHL fusion protein before incubation with the radiolabeled extract. The wt peptide is TLKERCLQWRSLVKP (underlined residues are sites of germ-line missense mutations). The mutant peptide is TLKERFLQWRSLVKP. Co-Immunoprecipitation Co-Immunoprecipitation the binding site for Elongin B and C the binding site for Elongin B and C in pVHL in pVHL Distribution of germ-line VHL mutations.
The shaded region represents the bidning site for Elongin B and C. Co-Immunoprecipitation Co-Immunoprecipitation
Binding of pVHL to Elongin B and
Binding of pVHL to Elongin B and
Elongin C in vivo
Elongin C in vivo
A. ACHN (VHL +/+), CAKI-1 (VHL +/
- ), 786-O (VHL -/-), and 293 (VHL +/+) cells were labeled with 35S-methione, lysed, and immunoprecipitated with anti-
VHL or a control antibody. The immunoprecipitaes were washed under high-salt conditions. The identification of pVHL(wt) (open arrow) was confirmed by anti-pVHL immunoblot analysis. The ~19 kD protein immediately above p18 (*) in the ACHN, CAKI-1, and 293 cell anti-VHL immunoprecipitates reacts with a polyclonal antibody to VHL.
B. Comparison of peptides generated by partial proteolysis of Elongin B and C, translated in vitro, with p18 and p14.
TAP: tandem affinity purification
TAP: tandem affinity purification Sequence and structure of the TAP tag Sequence and structure of the TAP tag
CBP TEV
Ig BD bait TAP
TAP
Overview of the TAP procedure Overview of the TAP procedure
TAP TAP
Schematic representation of the split TAP tag strategy TAP
TAP
Schematic representation of the substraction strategy TAP
TAP
Protein composition of TAP- purified U1 snRNP TAP
TAP
TAP TAP
Step-by-step analysis of the TAP strategy
Proteins present in the final TAP fraction (lanes 7 and 8), or present after each of the single affinity purification steps (lanes 1– 4), were analyzed. Snu71-TAP (lanes 1, 3, and 7) or wild-type extracts (lanes 2, 4, and 8) were used. Lane 5: molecular weight marker. Lane 6: an amount of TEV protease identical to the amount used to elute proteins bound to IgG beads (lanes 2, 3, 7, and 8). Right arrows indicate the U1 snRNP-specific proteins including the tagged Snu71p after TEV cleavage; the arrow on the left indicates the Snu71p protein fused to the TAP tag before TEV cleavage. TAP TAP
TAP in higher eucaryotes TAP in higher eucaryotes
Questions: overexpression endogenous expression Solutions: RNA interference Knockin technique
Strengths and weaknesses of commonly
used affinity approaches for the retrieval
of protein complexes
FRET:
FRET:
fluorescence resonance energy transfer
fluorescence resonance energy transfer
When will FRET occur? 1) Spectral overlap Donor emission spectrum must significantly overlap the absorption spectrum of the acceptor (>30%) 2) Distance between the donor and acceptor is between 2 - 10 nm 3) Favorable orientation of fluorophores Donor 2 ~ 10 nm emission Acceptor absorption FRET FRET
R = 4.9 nm 6 6 6 E: energy transfer efficiency E = R /(R + r )
R : intermolecular distance when half of energy is transfered r: distance between fluorophores when r = 2R , E = 1/65 FRET FRET
Imaging protein phosphorylation by FRET Imaging protein phosphorylation by FRET target GFP Fab Cy3 microinjection transfection or incubation laser target GFP Fab
Cy3 activator FRET FRET
Detection of protein interaction by FRET Detection of protein interaction by FRET Protein 2 target GFP Protein 2 YFP FITC Protein 1 Fab Cy3 Cy3 Protein 1 CFP in vitro phosphorylation in vivo
FRET reveals interleukin (IL)-1-
FRET reveals interleukin (IL)-1-
dependent aggregation of IL-1 type Idependent aggregation of IL-1 type I
receptors that correlates withreceptors that correlates with
receptor activation
receptor activation
FRET FRET FRET FRET
Abbreviation
Abbreviation
IL-1: interleukin 1
IL-1 RI: IL-1 type I receptor
IL-1ra: IL-1 receptor antagnist CHO-mu1c: CHO-K1 cells stably transfected with wild- type IL-1 receptor
CHO-extn: CHO-K1 cells stably transfected with cytoplasmic tail-truncated IL-1 receptor M5: noncompetitive anti-IL1 RI monoclonal antibody FITC-M5: M5 labeled with a donor probe, FITC Cy3-M5: M5 labeled with a acceptor probe, Cy3 FRET FRET
IL-1a -dependent FRET between donor
IL-1 -dependent FRET between donor FITC-M5 and acceptor Cy3-M5 bound to
FITC-M5 and acceptor Cy3-M5 bound to
IL-1 RI on the surface of CHO-mu1c cells
IL-1 RI on the surface of CHO-mu1c cells
IL-1aA, a mixture of 5 nM FITC-M5 and 5 nM Cy3-M5 6 IL-1ra ml) containing wild-type transfected receptors for was incubated with CHO-mu1c cells (3 X 10 cells/ control 50 min at 22 °C. IL-1a or IL-1ra was added at a final concentration of 30 nM immediately after the time point at t = 0 min (arrow), and changes in the ratio of Cy3-M5 fluorescence to FITC-M5 IL-1a fluorescence were monitored over time. Changes in this ratio were also monitored for the control sample to which no ligand was added. B, IL-1ra normalized fluorescence ratio for cells with added IL-1a or IL-1ra calculated from data in A. FRET FRET
IL-1a but not IL-1ra causes aggregation
IL-1a but not IL-1ra causes aggregation between IL-1 RI-labeled with FITC and Cy3 between IL-1 RI-labeled with FITC and Cy3
Fab fragments of M5 as detected by FRET
Fab fragments of M5 as detected by FRET
A mixture of 20 nM FITC-M5-Fab and 20 nM Cy3-M5-Fab was added to IL-1a CHO-mu1c cells transfected with wild-type receptors and incubated at IL-1ra 22 °C for 50 min. IL-1a or IL-1ra was added to a final concentration of 10 nM immediately after the time point at 0 min. Changes in the normalized ratio of Cy3-M5 Fab fluorescence to FITC- M5 Fab fluorescence were monitored over time at 22 °C. FRET FRET
IL-1-dependent energy transfer between IL-1 RI is temperature
A mixture of 20 nM FITC-M5 Fab and 12 nM Cy3-M5 Fab was added to CHO-mu1c cells (3 6 B X 10 cells/ml) with transfected wild-type IL-1 RI and preincubated at either 4 °C (A) or 22 °C (B) for 50 min. Immediately after the base-line data point at t = 0 min, IL-1a was added (arrow) A at a final concentration of 10 nM to both samples. Changes in the normalized ratio of
Cy3-M5 Fab fluorescence to FITC-M5 Fab fluorescence was monitored over time at the corresponding preincubation temperature. At t = 85 min, the temperature for sample (A) was changed from 4 to 22 °C, and the temperature for sample (B) was changed from 22 to 4 °C. Changes in the normalized fluorescence ratio continued to be monitored until t = 180 min. FRET FRET
IL-1a-dependent FRET can be detected between FITC-
M5 Fab and Cy3-M5 Fab bound to the cytoplasmic taildeleted mutant IL-1 RI on CHO-extn cells
A mixture of 20 nM FITC-M5 Fab and 12 nM Cy3-M5 Fab was added to wild-type A and incubated at 22 °C for 50 min (A). A transfected receptors on CHO-mu1c cells B mixture of 20 nM FITC-M5 Fab and 12 nM Cy3-M5 Fab was added to CHO-extn cells (cytoplasmic tail deleted mutant IL-1 RI) and incubated at 22 °C for 50 min (B). IL-1a was added to a final concentration of 20 nM at the arrow, and changes in the normalized ratio of Cy3-M5 Fab fluorescence to FITC- M5 Fab fluorescence were monitored over time at 22 °C.
SPR: Surface Plasma Resonance
SPR: Surface Plasma Resonance
Diagram of BIAcore Diagram of BIAcore
SPR SPR
Interactions between lectins and immobilized glycoproteins SPR
SPR
SPR SPR
Interactions between lectins and immobilized glycoproteins
An overlay plot of binding curves showing the interaction between lectins and immobilized thyroglobulin.
Lectin solutions (50 µg/ml in 10 mM HEPES, 0.5 mM MnCl2 , 0.5 M CaCl2 and 0.05% surfactant, pH 7.4) were injected. Bound lectin was dissociated by 100 mM HCl (15 µl, 5 µl/min). SPR SPR
Summary of the interaction of seven lectins of different nominal specificities with immobilized glycoproteins
Binding of lectin to the glycoprotein is indicated by “+” and lack of binding by “-” in the above table. As control experiments, the lectins were injected over (i) an immobilized non-glycosylated protein (recombinant HIV-1 reverse transcriptase expressed in E. coli) and (ii) a blank surface which was subjected to immobilizationchemistry in absence of a protein. The lectins did not show any binding in the control experiments. SPR SPR
SPR-MS: Ligand Fishing with SPR-MS:
Biacore 3000
Detection Identification
Selective binding, recovery and identification by MALDI MS of a specific interaction partner
Other important techniques in
Other important techniques in
protein interaction researchprotein interaction research
Mass Spectrometry Cross-linking Ultracentrifuge ChIP (Chromatin immunoprecipitation)
Mass Spectrometry
Mass spectrometry is indispensable for protein identification
Mass spectrometry is indispensable for protein identification
and will be in the center of proteomics research. and will be in the center of proteomics research.High sensitivity High resolution High throughput
Reference data bases
Reference data bases
Prediction server
Interactions
- – Predictome (Boston U)
- – MIPS
- – Plex (UTexas)
- – DIP
- – STRING (EMBL)
- – YPD
- – Intact (EBI)
- – BIND/ Blueprint
Protein complexes
- – GRID
- – MIPS
- – MINT
- – YPD
From defining the proteome
to understanding functionThanks!